GENMAB A/S Quarterly Research And Development Expense in DKK from Q2 2018 to Q2 2024

Taxonomy & unit
ifrs-full: DKK
Summary
Genmab A/S annual/quarterly Research And Development Expense history and growth rate from Q2 2018 to Q2 2024.
  • Genmab A/S Research And Development Expense for the quarter ending June 30, 2024 was 2.5B DKK, a 35% increase year-over-year.
  • Genmab A/S annual Research And Development Expense for 2024 was 9.75B DKK, a 27.8% increase from 2023.
  • Genmab A/S annual Research And Development Expense for 2023 was 7.63B DKK, a 37.2% increase from 2022.
  • Genmab A/S annual Research And Development Expense for 2022 was 5.56B DKK, a 33% increase from 2021.
Research And Development Expense, Quarterly (DKK)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 2.5B +649M +35% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-08
Q2 2023 1.85B +571M +44.5% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-08
Q2 2022 1.28B +361M +39.2% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-03
Q2 2021 921M +146M +18.8% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-10
Q2 2020 775M +211M +37.4% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-11
Q2 2019 564M +245M +76.9% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-12
Q2 2018 319M Apr 1, 2018 Jun 30, 2018 6-K 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.